x

Search for a clinical trial

* (*) mandatory field

347 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

AUSTRIA

OBERÖSTERREICH
LINZ

AUSTRIA

SALZBURG
SALZBURG

AUSTRIA

TIROL
INNSBRUCK

AUSTRIA

TIROL
INNSBRUCK

AUSTRIA

WIEN
WIEN

AUSTRIA

WIEN
WIEN

Treatment of Chronic Lymphocytic Leukemia With the Use of an Antiviral Compound - a Proof of Principle Study (Phase 4)
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Infektionen und Tropenmedizin

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
LOUVAIN-LA-NEUVE

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
LOUVAIN-LA-NEUVE

FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

FRANCE

BRETAGNE
RENNES

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Baden-Württemberg
HEIDELBERG

Ongoing trial
CURATIVE Trial: A phase-III study on the value of allogeneic stem cell transplantation in poor-risk chronic lymphocytic leukemia
Zentrum für Innere Medizin (Krehl-Klinik)
Abteilung Innere Medizin V - Sektion Allogene Stammzelltransplantation

GERMANY

Baden-Württemberg
TÜBINGEN

Phase I/II study of haploidentical hematopoietic cell transplantation with CD3/CD19 depleted grafts in patients with treatment refractory hematologic malignancies - DE
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin II - Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmologie

GERMANY

Bayern
MÜNCHEN

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Berlin
ADDRESS: NOT PROVIDED - DE

GERMANY

Nordrhein-Westfalen
KÖLN

GERMANY

Nordrhein-Westfalen
MÜNSTER

Recruiting trial
Ongoing trial
A Phase I/II Safety, Dose Finding and Feasibility Trial of MB-CART19.1 in Patients With Relapsed or Refractory CD19 Positive B Cell Malignancies
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

ITALY

CAMPANIA
NAPOLI

ITALY

LAZIO
ROMA

Phase I-II Multicenter Study to Assess the Efficacy and Safety of the Chlorambucil + Lenalidomide Combination and Lenalidomide Maintenance Therapy in Untreated Elderly Pts With CLL
Sapienza Università di Roma - Dipartimento di Neurologia e Psichiatria
Dipartimento di Biotecnologie Cellulari ed Ematologia

ITALY

LAZIO
ROMA

Ongoing trial
A Phase 2 Multicenter Study to Assess the Activity and the Safety of Front-line Ibrutinib Plus Rituximab (IR) in Unfit Patients With Chronic Lymphocytic Leukemia (CLL)
Sapienza Università di Roma - Dipartimento di Neurologia e Psichiatria
Dipartimento di Biotecnologie Cellulari ed Ematologia

SPAIN

Andalucía
CÁDIZ

Recruiting trial
Ongoing trial
LYMRIT-37-01: A Phase I/II Study of 177Lu-HH1 (Betalutin®) Radioimmunotherapy for Treatment of Relapsed Non-Hodgkin Lymphoma - ES
Hospital Universitario Puerta del Mar
Unidad clínica de Hematología, Inmunología y Genética

SPAIN

Andalucía
SEVILLA

SPAIN

Castilla - León
SALAMANCA

SPAIN

Cataluña
SABADELL

Recruiting trial
Ongoing trial
LYMRIT-37-01: A Phase I/II Study of 177Lu-HH1 (Betalutin®) Radioimmunotherapy for Treatment of Relapsed Non-Hodgkin Lymphoma - ES
Corporación Sanitaria Parc Taulí. Hospital de Sabadell
Servicio de Hematología y Hemoterapia

SPAIN

Comunidad Valenciana
VALENCIA

SPAIN

Comunidad Valenciana
VALENCIA

SPAIN

Comunidad Valenciana
VALENCIA

Recruiting trial
Ongoing trial
Dose Optimization Study of Idelalisib in Follicular Lymphoma and Small Lymphocytic Lymphoma (Phase III) - ES
Hospital Universitario y Politécnico La Fe
Servicio de Oncología Médica

SPAIN

Comunidad Valenciana
VALENCIA

SPAIN

Madrid
MADRID

Recruiting trial
Ongoing trial
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study - ES
Hospital Universitario Fundación Jiménez Díaz
Servicio de Hematología y Hemoterapia

SPAIN

Madrid
MAJADAHONDA

Recruiting trial
Ongoing trial
LYMRIT-37-01: A Phase I/II Study of 177Lu-HH1 (Betalutin®) Radioimmunotherapy for Treatment of Relapsed Non-Hodgkin Lymphoma - ES
Hospital Universitario Puerta de Hierro - Majadahonda
Servicio de Oncología Médica

SPAIN

Navarra
PAMPLONA

Recruiting trial
Ongoing trial
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study - ES
Clínica Universidad de Navarra
Servicio de Hematología y Hemoterapia

UNITED KINGDOM

Devon
PLYMOUTH

Recruiting trial
Ongoing trial
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study - UK
Plymouth Derriford Hospital
British National Lymphoma Institute Research Group

UNITED KINGDOM

Lancashire
LIVERPOOL

Ongoing trial
RIAltO: A Randomised Investigation of Alternative Ofatumumab-containing regimens in less fit patients with CLL
University of Liverpool Cancer Research Centre
Cancer Research UK Liverpool Cancer Trials Unit

UNITED KINGDOM

West Midlands
BIRMINGHAM

Ongoing trial
A phase II trial of Cyclosporin A in Early Adverse Risk CLL - CyCLLe
University of Birmingham
School of Cancer Sciences

UNITED KINGDOM

West Midlands
BIRMINGHAM

UNITED KINGDOM

West Yorkshire
LEEDS

Recruiting trial
Ongoing trial
COSMIC: Combination FC plus Ofatumumab at Standard or Mega dose In CLL (Phase II)
St James's University Hospital
Clinical Haematology (Bexley Wing)

UNITED KINGDOM

West Yorkshire
LEEDS

ITALY

LOMBARDIA
ROZZANO

Ofatumumab-Bendamustine For Relapsed-Refractory Indolent Lymphoma: A Multicenter Phase 2 Trial
IRCCS Istituto Clinico Humanitas
U.O. Oncologia Medica ed Ematologia

SPAIN

Comunidad Valenciana
VALENCIA

DYNAMO: A Phase 2 Study of IPI-145 in Subjects with Refractory Indolent Non-Hodgkin Lymphoma - ES (Completed)
Hospital Universitario y Politécnico La Fe
Servicio de Oncología Médica

UNITED KINGDOM

South Glamorgan
CARDIFF

FRANCE

AUVERGNE-RHONE-ALPES
PIERRE-BENITE

GERMANY

Nordrhein-Westfalen
KÖLN

SPAIN

Madrid
MADRID

Recruiting trial
Ongoing trial
A phase I/II, multicenter, open-label study of MAK683 in adult patients with advanced malignancies - ES
Hospital Universitario 12 de Octubre
Unidad de Ensayos Clínicos de Fase Temprana en Hematología

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

FRANCE

ILE-DE-FRANCE
PARIS

Treatment of aggressive lymphoma in adults: NHL 98
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Institut Universitaire d'Hématologie

FRANCE

PAYS DE LA LOIRE
NANTES

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Intensive sequential chemotheray in non hodgkin lymphoma (NLH) of patients suffering from HIV- CIS VIH 02 (Phase IV) - trial stopped -
CLCC Institut Paoli Calmettes
Unité d'Evaluation Thérapeutique en Onco-Hématologie (ETHO)

GERMANY

Baden-Württemberg
TÜBINGEN

Pegfilgrastim vs. filgrastim - comparison of mobilized blood stem cells in patients with Non-Hodgkin lymphoma (Phase II) - DE
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin II - Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmologie

ITALY

EMILIA ROMAGNA
BOLOGNA

Recruiting trial
Ongoing trial
Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Policlinico S. Orsola-Malpighi - Area S. Orsola
Dipartimento di Ematologia e Scienze Oncologiche

NETHERLANDS

Gelderland
NIJMEGEN

NETHERLANDS

Noord-Holland
AMSTERDAM

Low dose radiotherapy (2x 2 Gy) in low grade Non-Hodgkin lymphomas (Completed)
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Afdeling Radiotherapie

NETHERLANDS

Zuid-Holland
ROTTERDAM

Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
Erasmus MC, Locatie Daniel den Hoed
Erasmus MC Kanker Instituut Daniel den Hoed

SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

SPAIN

Comunidad Valenciana
VALENCIA

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques Universitaires UCL Saint-Luc
Pneumologie_Oncologie thoracique

Multinational clinical trial(s)

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US